Is she referring to this? Here, this phase II is no longer recruiting but "Subjects who complete Part A and meet certain response criteria will be invited to enroll in Part B. Part B is an open-label extension and eligible subjects will receive VX-770 twice daily for up to 96 weeks."
<a target=_blank class=ftalternatingbarlinklarge href="http://www.clinicaltrials.gov/ct2/show/study/NCT00953706">clinicaltrials.gov- VX-770 phase II</a>